Back to VG Vanguard Global Advisers, LLC
XLO2 quarters
Position history for VGVanguard Global Advisers, LLC's holdings in XILIO THERAPEUTICS INC
Vanguard Global Advisers, LLC previously held 0 shares of XLO (XILIO THERAPEUTICS INC), worth $0 as of 2026-Q2.
Final Value
$0
Final Shares
0
Total Value Change
-$1,766
Total Shares Change
-210
Quarter-by-Quarter History
Other major holders of XLO: VANGUARD CAPITAL MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY